Skip Ribbon Commands
Skip to main content


TricValve® - What it is

The TricValve®, also known as transcatheter bicaval valves system, is a minimally invasive procedure to address the effects of severe tricuspid regurgitation, for patients who are at high risk or unsuitable for open heart surgery.

TricValve bioprosthetic valves implanted
Illustration of TricValve bioprosthetic valves implanted to superior and inferior vena cava (Image courtesy of OrbusNeich)

The National Heart Centre Singapore (NHCS) is the first centre in Singapore to offer this treatment since December 2021 and to-date successfully performed three cases. The TricValve procedure is also part of the comprehensive suite of treatment options offered at NHCS, for patients with severe heart valve disease. The treatment options ranges from medication therapies, minimally invasive (percutaneous or transcatheter) procedures, and surgical treatments to repair or replace the damaged valve.

​In this procedure, two bioprosthetic valves are placed in the venous system (one in the superior vena cava and another in the inferior vena cava) to reduce the backflow of blood and pressure on the other organs of the body.

TricValve transcatheter bicaval valves (bioprosthesis)
Samples of TricValve transcatheter bicaval valves (bioprosthesis) (Image courtesy of OrbusNeich)

While TricValve is a relatively new procedure for which studies on long-term clinical outcomes are ongoing, it provides an additional option for patients with significant symptoms and are deemed unsuitable for surgery.

TricValve® - Symptoms

TricValve® - How to prevent?

TricValve® - Causes and Risk Factors

TricValve® - Diagnosis

TricValve® - Treatments

TricValve® - Preparing for surgery

TricValve® - Post-surgery care

The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

Discover articles,videos, and guides afrom Singhealth's resources across the web. These information are collated, making healthy living much easier for everyone.